00000000nam 2200000zi 4500
0019.950624
003CaOODSP
00520250708160408
006m     o  d f      
007cr cn|||||||||
008250430t20252025onc     ob   f000 0 eng d
020 |a9780660770857
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-653/2025E-PDF
24500|aMpox immunization coverage among 2SLGBTQI+ 2024-25 : |bmethodological report.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2025.
264 4|c©2025
300 |a1 online resource (36 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Enquête sur la couverture vaccinale contre la variole simienne chez les 2ELGBTQI+, 2024-25.
500 |aPrepared for the Public Health Agency of Canada.
500 |a"Supplier name: Advanis Inc."
500 |a"Contract number: 6D142-24-7502."
500 |a"Registration number: POR 080-24."
504 |aIncludes bibliographical references.
650 0|aHuman monkeypox|xVaccination|zCanada|xPublic opinion.
650 0|aPublic opinion|zCanada.
650 0|aSexual minorities|zCanada|xAttitudes.
7102 |aPublic Health Agency of Canada, |eissuing body.
7102 |aAdvanis (Firm), |econsultant.
77508|tEnquête sur la couverture vaccinale contre la variole simienne chez les 2ELGBTQI+, 2024-25 / |w(CaOODSP)9.950626
85640|qPDF|s698 KB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/H14-653-2025-eng.pdf